2026 ICD-10-CM Diagnosis Code T46.4X1APoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter

ICD-10-CM CodesS00–T88T36-T50T46

ICD-10-CM T46.4X1A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T46.4X1A is a billable ICD-10-CM diagnosis code for poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. Coders also document this condition as accidental overdose by angiotensin-converting enzyme inhibitor. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under External cause codes: intent of injury, accidental/unintentional; External cause codes: poisoning by drug; and Poisoning by drugs, initial encounter.

Code Identity

ICD-10-CM Code
T46.4X1A
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
Short Description
Poisoning by angiotens-convert-enzyme inhibitors, acc, init
Parent Code
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT46Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
This CodeT46.4X1APoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Accidental overdose by angiotensin-converting enzyme inhibitor
  • Accidental poisoning by angiotensin-converting enzyme inhibitor
  • Overdose of angiotensin-converting-enzyme inhibitors
  • Poisoning by angiotensin-converting-enzyme inhibitors

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (T46). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR EXT020
External cause codes: intent of injury, accidental/unintentional
Default principal diagnosis: inpatient No · outpatient No
CCSR EXT014
External cause codes: poisoning by drug
Default principal diagnosis: inpatient No · outpatient No
CCSR INJ022
Poisoning by drugs, initial encounter
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Captopril

    a potent and specific inhibitor of peptidyl-dipeptidase a. it blocks the conversion of angiotensin i to angiotensin ii, a vasoconstrictor and important regulator of arterial blood pressure. captopril acts to suppress the renin-angiotensin system and inhibits pressure responses to exogenous angiotensin.
  • Cilazapril

    one of the angiotensin-converting enzyme inhibitors (ace inhibitors) used for hypertension. it is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat.
  • Enalapril

    an angiotensin-converting enzyme inhibitor that is used to treat hypertension and heart failure.
  • Enalaprilat

    the active metabolite of enalapril and one of the potent, intravenously administered, angiotensin-converting enzyme inhibitors. it is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. the drug produces renal vasodilation with an increase in sodium excretion.
  • Fosinopril

    a phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. it is a prodrug that is converted to its active metabolite fosinoprilat.
  • Lisinopril

    one of the angiotensin-converting enzyme inhibitors (ace inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.
  • Perindopril

    an angiotensin-converting enzyme inhibitor. it is used in patients with hypertension and heart failure.
  • Quinapril

    a tetrahydroisoquinoline derivative and angiotensin converting enzyme inhibitor that is used in the treatment of hypertension and heart failure.
  • Ramipril

    a long-acting angiotensin-converting enzyme inhibitor. it is a prodrug that is transformed in the liver to its active metabolite ramiprilat.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AlaceprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
BenazeprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
CaptoprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
CilazaprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
EnalaprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
EnalaprilatT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
FosinoprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
Fosinopril::sodiumT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
InhibitorT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
Inhibitor::angiotensin-converting enzymeT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
Inhibitor::carbonic anhydraseT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
Inhibitor::fibrinolysisT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
Inhibitor::monoamine oxidase NECT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
Inhibitor::monoamine oxidase NEC::hydrazineT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
Inhibitor::postsynapticT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
Inhibitor::prothrombin synthesisT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
LisinoprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
PerindoprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
QuinaprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
RamiprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
SpiraprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6
ZofenoprilT46.4X1T46.4X2T46.4X3T46.4X4T46.4X5T46.4X6

Patient EducationClinical

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T46.4X1A to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
972.6 Pois-antihyperten agent
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E858.3 Acc poisn-cardiovasc agt
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T46.4X1AOverview

Is T46.4X1A a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character A in T46.4X1A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), such as an emergency visit or first evaluation.

What MS-DRG does T46.4X1A group to?

When poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter is the principal diagnosis on an inpatient stay, it groups to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of T46.4X1A?

Under the General Equivalence Mappings, poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter converts to ICD-9-CM 972.6 (pois-antihyperten agent) and E858.3 (acc poisn-cardiovasc agt). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.